Results 121 to 130 of about 38,007 (143)
Some of the next articles are maybe not open access.

Extended-interval dosing of natalizumab in NOVA – Authors' reply

The Lancet Neurology, 2023
John F, Foley   +2 more
openaire   +2 more sources

Potential for extending the chloramphenicol dosing interval for canine urinary tract infections

Journal of Veterinary Pharmacology and Therapeutics
AbstractCanine urinary excretion of chloramphenicol was evaluated to optimize a dosing protocol for treating urinary tract infections. Seven healthy male intact purpose‐bred Beagles and six healthy client‐owned dogs of various breeds each received a single oral 50 mg/kg dose of chloramphenicol.
Kate S. KuKanich   +3 more
openaire   +2 more sources

Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine

Pediatrics
BACKGROUNDNine-valent human papillomavirus (9vHPV) vaccines can be administered in 2 doses 6 to 12 months apart in adolescents. The impact of extended dose intervals is unknown. We report immunogenicity and safety data in adolescents of a second 9vHPV vaccine dose administered ≥1 year after the first.METHODSThis open-label safety and immunogenicity ...
Nicola P, Klein   +10 more
openaire   +2 more sources

Extended dosing of monoclonal antibodies in multiple sclerosis

Multiple Sclerosis Journal, 2022
Zoe Van Kempen   +2 more
exaly  

Effectiveness of Natalizumab in Extended Dosing Interval (P3.078)

Neurology, 2016
Jose Vicente Hervas   +8 more
openaire   +1 more source

Efficacy of Omalizumab Using Extended Dose Intervals

Journal of Allergy and Clinical Immunology, 2007
R.M. Katz   +6 more
openaire   +1 more source

COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients

Journal of Neurology, 2023
Alvino Bisecco   +2 more
exaly  

Extended Interval Gentamicin Dosing in Burn Patients

Journal of Burn Care & Rehabilitation, 2001
K. L. Brown   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy